1. Malaysia Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Kotra Industries Bhd.

Kotra Industries Bhd.

MMYX:KOTRA
3.70
MYR
0.00
(0.00%)
13.59P/E
Dec 01Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1.12
1.1
1.21
1.25
1.34
1.24
1.19
1.08
1.41
1.64
1.53
1.56
- -
1.57
Basic EPS, GAAP
0.04
0.01
0.06
0.09
0.12
0.16
0.2
0.17
0.42
0.44
0.3
0.29
- -
0.27
Free Cash Flow per Basic Share
0.05
0.16
0.12
0.23
0.22
0.18
0.33
0.28
0.38
0.27
0.11
0.14
- -
-0.04
Dividend per Share
- -
- -
- -
0.02
0.04
0.06
0.09
0.07
0.17
0.26
0.28
0.25
- -
0.09
Book Value per Share
0.9
0.92
0.99
1.07
1.14
1.2
1.31
1.4
1.65
1.83
1.86
1.89
1.94
1.94
Tangible Book Value per Share
0.9
0.92
0.99
1.07
1.14
1.2
1.31
1.4
1.65
1.83
1.86
1.89
1.94
1.94
Basic Weighted Avg Shares
132
132
132
133
133
139
145
148
148
148
148
148
- -
148
Sales/Revenue/Turnover
147
145
160
166
178
173
172
160
208
242
227
231
233
233
Operating Margin (%)
7.6
2.41
7.74
9.21
10.73
12.45
14.81
16.22
26.72
24.96
21.8
22.26
22.27
22.27
Depreciation Expense
11
12
13
13
14
14
16
16
15
15
14
14
15
15
Net Income, GAAP
6
1
8
12
16
22
30
24
62
65
45
42
41
41
Effective Tax Rate (%)
1.82
10.02
1.32
1.01
0.97
- -
- -
7.17
- -
1.27
21.03
17.29
21.4
21.4
Profit Margin (%)
3.84
0.73
4.84
7.45
8.82
12.86
17.21
15.28
29.87
26.93
19.68
18.4
17.42
17.42
Working Capital
32
33
36
49
56
60
72
90
127
127
98
77
75
75
LT Debt
84
76
67
57
46
31
18
7
- -
- -
- -
2
23
23
Total Equity
119
122
131
142
153
172
190
206
244
271
275
280
288
288
Return on Invested Capital (%)
4.66
1.36
5.4
6.86
8.97
- -
- -
10.88
- -
22.93
14.27
15.15
13.54
13.54
Return on Capital (%)
5.75
3.43
6.44
8.24
9.58
- -
- -
11.26
- -
24.97
16.27
15.2
13.7
13.7
Return on Common Equity (%)
4.99
0.88
6.14
9.07
10.67
13.64
16.33
12.31
27.56
25.32
16.32
15.29
14.29
14.29

Capital Structure

MYR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'26
ST Debt
- -
- -
2
LT Borrowings
24
24
23
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
148
148
148
Market Capitalization
616
601
552

Working Capital

MYR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'26
Total Current Assets
141
134
131
Cash, Cash Equivalents & STI
49
44
35
Accounts Receivable, Net
39
38
39
Inventories
51
49
52
Total Current Liabilities
54
52
56
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
2
Deferred Revenue
- -
- -
- -

Growth Rates

MYR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.29%
7.09%
2.84%
Free Cash Flow
0.14%
-29.59%
-128.25%
Net Income, GAAP
26.22%
23.76%
-4.43%
Sales/Revenue/Turnover
4.34%
8.63%
0.97%
Total Cash Common Dividend
- -
39.35%
-13.73%

Quarterly Revenue

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
53
58
56
60
227
2025
66
54
58
52
231
2026
58
61
52
61
233

Quarterly Earnings Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
0.08
0.05
0.08
0.3
2025
0.07
0.07
0.08
0.07
0.29
2026
0.07
0.07
0.05
0.08
- -

Quarterly Dividends Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.13
- -
0.28
2025
- -
- -
- -
- -
0.25
2026
- -
- -
- -
0.09
- -

Company Description

Company Profile APIChatGPT
CEO
Teck Onn Piong
Full Time Employees
720
Sector
Health technology
Industry
Pharmaceuticals: major
Address
Cheng Industrial Estate Melaka ME Malaysia 75250
IPO Date
Oct 30, 2000
Website
kotrapharma.com
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Kotra Industries Berhad (KLCI: 0002) manufactures and distributes a range of pharmaceutical and healthcare products, including generic drugs, over-the-counter medications, and medical supplies. The company offers core products such as antibiotics, analgesics, vitamins and supplements, topical ointments, and herbal-based remedies under its own brands like Kotra Pharma and associated labels; it also provides contract manufacturing services for third-party pharmaceutical formulations and packaging solutions. Headquartered in Shah Alam, Selangor, Malaysia, and founded in 1979, Kotra Industries operates primarily in Southeast Asia, with distribution networks across Malaysia, Singapore, Indonesia, and export markets in the Asia-Pacific region, serving pharmacies, hospitals, clinics, and retail chains. The company focuses on the healthcare and consumer goods segments, targeting both institutional buyers and end-consumers seeking affordable, quality-assured medications. In recent developments, Kotra Industries expanded its production capacity through a strategic investment in a new manufacturing facility in 2024, enhancing output for high-demand generic antibiotics and sterile injectables to meet growing regional demand. The company formed a key distribution partnership with a leading Indonesian pharmaceutical distributor in early 2025, bolstering its market penetration in Southeast Asia's emerging markets. Additionally, Kotra launched a new line of bio-equivalent generic cardiovascular drugs in late 2024, alongside compliance upgrades to international GMP standards, positioning it for potential exports to regulated markets.